A month after laying off 20% of its employees, Palisade Bio’s CEO is also out the door. Thomas Hallam hit the exit on Monday and finance chief JD Finley took over as interim CEO.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,